| Section | Status | Black Triangle | Name |
| 08.03.04.01 | Formulary |  |
Abemaciclib tabs |
| 06.01.02.03 | Formulary | |
Alogliptin |
| 03.04.02 | Formulary | |
Benralizumab Fasenra |
| 08.01.05 | Formulary | |
Brigatinib Alunbrig |
| 06.01.02.03 | Formulary | |
Canagliflozin |
| 08.01.05 | Formulary | |
Cemiplimab |
| 13.05.03.02 | Formulary | |
Certolizumab pegol Cimzia 200mg/ml injection |
| 08.03.04.02 | Formulary | |
Darolutamide Nubeqa |
| 08.01.05 | Formulary | |
Durvalumab Imfinzi |
| 06.01.02.03 | Formulary | |
Empagliflozin |
| 08.01.05 | Formulary | |
Entrectinib Rozlytrek® 100mg and 200mg |
| 06.01.02.03 | Restricted Use | |
Ertugliflozin Steglatro |
| 06.01.02.03 | Formulary | |
Exenatide prolonged release Bydureon® |
| 04.07.04.02 | Formulary | |
Fremanezumab Ajovy ® |
| 04.07.04.02 | Formulary | |
Galcanezumab Emgality |
| 04.07.04.02 | Formulary | |
Galcanezumab Emgality |
| 08.02.03 | Formulary | |
Isatuximab injection |
| 08.01 | Formulary | |
Larotrectinib VITRAKVI ® |
| 08.01.05 | Formulary | |
Lenvatinib Lenvima® |
| 10.01.04 | Non Formulary | |
Lesinurad Zurampic® |
| 01.06.07 | Formulary | |
Linaclotide Constella® |
| 06.01.02.03 | Formulary | |
Linagliptin |
| 06.01.02.03 | Formulary | |
Lixisenatide |
| 08.01 | Formulary | |
Lorlatinib Lorviqua |
| 01.06.06 | Formulary | |
Methylnaltrexone Relistor® |
| 08.01.05 | Formulary | |
Midostaurin Rydapt |
| 01.06.06 | Formulary | |
Naloxegol |
| 08.03.04.01 | Formulary | |
Palbociclib Ibrance |
| 08.03.04.01 | Formulary | |
Ribociclib tabs |
| 13.05.03.02 | Formulary | |
Risankizumab Skyrizi |
| 04.09.01 | Restricted Use | |
Safinamide |
| 06.01.02.03 | Formulary | |
Semaglutide Omzempic |
| 08.02.04 | Formulary | |
Siponimod Mayzent Tablets |
| 05.03.03.02 | Formulary | |
Sofosbuvir/velpatasvir/voxilaprevir Vosevi |
| 08.02.02 | Formulary | |
Tacrolimus modified release Envarsus |
| 13.05.03.02 | Formulary | |
Tildrakizumab Ilumetri 100mg/ml injection |
| 01.05.03 | Formulary | |
Tofacitinib |
| 01.05.03 | Formulary | |
Vedolizumab |